The Latest Breaking News from Epilepsy

Avicanna Inc. (OTCQX: AVCNF) (TSX:AVCN) (FSE:0NN), a commercial stage, international biopharmaceutical company focused on the commercialization of evidence-based, cannabinoid-based products, has expanded its research collaboration in field of epilepsy with a new collaboration with the

EPILEPSY Scotland has launched a month-long campaign to increase awareness of epilepsy amongst students in colleges and universities across Scotland.

The US Food and Drug Administration (FDA) has accepted for filing Krystal Biotech’s (NASDAQ:KRYS) Biologics License Application (BLA) for its lead candidate B-VEC in the treatment of patients with dystrophic epidermolysis bullosa (DEB). The regulatory agency has granted  Priority Review designation and assigned a target actin date of February 17,…

Callum suffered serious injury as a toddler which left him blind and deaf, while he was also diagnosed with quadriplegia cerebral palsy and epilepsy.

Avicanna (OTCQX: AVCNF), a biopharmaceutical company focused on cannabinoid-based products, released its Q2 2022 highlights:

A child diagnosed with a rare form of epilepsy which causes her to have multiple seizures a day is to undergo life-saving surgery to detach part of her brain.

Thea Steele was diagnosed with a rare form of epilepsy which can cause 'catastrophic' damage

Kodiak Sciences Inc. (NASDAQ:KOD) announced positive topline results its BEACON Phase 3 study of tarcocimab tedromer (KSI-301; tarcocimab) in patients with macular edema due to retinal vein occlusion. Kodiak shares traded in a range of $10.02 to $11.79 on a day volume of 4.05 million shares, closed regular trading session…

Little Thea Steele was also diagnosed with extensive cortical dysplasia and intractable epilepsy, which left her resistant to medication - and suffering from seizures every day.